furious

k d Joined Jun 20, 2013

I'm new, but learning something everyday. I like bios/ tech, but they must have fundamentals. Read everything you can. P.S. If you try to pick the bottom every time, all you get is sticky fingers. P.P.S Use stops.

Following

  1. Thumb-1396909516
    barna
    Barna

    28 year old full time trader specializing in BioPharm. Targeting beaten and bruised Biotechs based on strong fundamentals. #LGR.
  2. Thumb-1361659530
    IPOTrader
    John Noland

  3. Thumb-1309697363
    upsidetrader
    joe donohue

    Full time trader. On Wall St. for over twenty years. Founder long/short hedge fund. Currently manages private accounts and personal money with a long/short strategy. To request my performance, e-mail me at upsidetrader@gmail.com
  4. Thumb-1352902831
    BVHealthcare
    BV Healthcare

  5. Thumb-1384400908
    JasonMD
    JasonMD

    19 years of experience and practices in Internal Medicine and Gastroenterology. Investor in small cap biotechs.
  6. Thumb-1367025606
    BioDueDiligence
    Andrew G.

    Professional scientific skeptic and biotech/pharma commentator. Follow my writing on BiotechDueDiligence, HSP90 Central, SeekingAlpha, Chimera Research Group
  7. Thumb-1326594905
    EXPstocktrader
    EXPstocktrader

  8. Thumb-1397113018
    Keynesonomics
    Keynesonomics

    Penn State Econ major~Scholar of Behavioral Finance & 30yr mkt trader~Proponent of the notion that psychology & emotion recurrently contest the efficient market hypothesis*DISCLAIMER:NEVER trade any security based on my opinions~Live Life~Smile Often
  9. Thumb-1390480259
    micheleciani
    Michele Ciani

    Expert stocks trader, trading on technical charts, in-depth studies, analysis and rumors. Focus on Small cap Biotech and new emerging Healthcare company.
  10. Thumb-1362074089
    ACE52WeekHigh
    AceMoneyPicks

    Day, swing, momentum, and value trader. A combination of technical, fundamentals, & contrarian trading. Macro Economics
  11. Thumb-1389705208
    PowerTriggerTrade
    Sandro

    Developer of the Power trigger lines system that minimizes false signals and maximizes strong entry signals with buy points to confirm the trade. I only will respond to my followers
  12. Thumb-1382995107
    DaytradeWarrior
    Ross Cameron

    I'm a Daytrade Moderator in the largest stock trading chatroom on the web alerting my trades all day long
  13. Thumb-1373126630
    Finch_31
    Jason Fisch

    Stats as of 2012 :: Portfolio: +9.08% w/ 15 Open Positions (4 Years) // 20 Wins / 29 Trades (69%) // Best Trade: +146.22% // Avg Win: 19.75% // Avg Loss: -24.48% [Follow Portfolio & Disclaimer @ www.StocksNBiz.com]
  14. Thumb-1397763448
    Talib_Gunther
    Talib Gunther

    Full time independent trader. Master's degree from the University of Washington. Long/short chartist targeting daytrades, swings, MOMO, and scalps. Operating strategies incorporate technical analysis + behavioral psychology
  15. Thumb-1341968079
    RalfKaiser
    Ralf Kaiser

    ♦ Aficionado of Optimal Trading Strategies in Stocks, ETFs, ES Futures and Forex ♦ Incorporating effective strategies in to high performing portfolios ♦ Husband to ONE; Father to THREE ♦
  16. Thumb-1355781853
  17. Thumb-1357779087
    Catalyst_Fun
    Vincent

    Some Biotechs, Swing+Position Trades. Diversify,Patience,Risk Mgmt.Technicals+Fundamentals/valuation. I'm also on Twitter. *Disclaimer: Your investment/trading decisions are solely your own responsibility.AlwaysDoYourOwnDD.* HappyTrading!
  18. Thumb-1395701972
    AlgoSniffer
    Gonzo Chinaski

    Swing trade using our real-time watchlist created w/ @BioBounce. Buy in the entry zone and take profits at the targets. Register at site for 21day Trial - link below:
  19. Thumb-1366329606
    AceOfSpades
    Andrew Colburn

    First year trading 280% growth -- 2012 (biotechs). Currently have a full position in $AMRN. ~35% growth in my Dad's IRA (Jun-Dec2012).
  20. Thumb-1395565555
    russdorff
    Russell Deardorff

    ( Barge Captain) U.S. Merchant Marine, 32 years. Amateur investor since 97, intrigued with Bio-Tech stocks since 2/12, after doubling investment with VIVUS phase III data